BeOne Medicines Ltd.
ONC
58 insider filings · Latest: Oct 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | May 22 8:22 PM | ALESSANDRO RIVA | Proposed Sale | 212 | $309.51 | $65.6K | — | View → |
| May 22, 2026 | May 22 8:20 PM | MARGARET DUGAN | Proposed Sale | 212 | $309.60 | $65.6K | — | View → |
| May 22, 2026 | May 22 8:18 PM | CORAZON D. SANDERS | Proposed Sale | 212 | $309.59 | $65.6K | — | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Sale | 332 | $310.72 | $103.2K | 0(D) | View → |
| May 13, 2026 | May 13 8:27 PM | CHAN LEE | Proposed Sale | 1,328 | $315.07 | $418.4K | — | View → |
| Apr 8, 2026 | Apr 10 9:40 PM | Chan Henry LeeSVP, General Counsel | Sale | 332 | $311.59 | $103.4K | 0(D) | View → |
| Mar 11, 2026 | Mar 13 9:26 PM | Chan Henry LeeSVP, General Counsel | Sale | 341 | $300.00 | $102.3K | 0(D) | View → |
| Feb 4, 2026 | Feb 6 9:57 PM | Chan Henry LeeSVP, General Counsel | Sale | 1,660 | $349.52 | $580.2K | 0(D) | View → |
| Feb 4, 2026 | Feb 4 9:21 PM | CHAN LEE | Proposed Sale | 4,676 | $346.38 | $1.6M | — | View → |
| Dec 15, 2025 | Dec 15 9:32 PM | JOHN V OYLER | Proposed Sale | 100,000 | $319.06 | $31.9M | — | View → |
| Nov 26, 2025 | Nov 26 9:13 PM | CORAZON D. SANDERS | Proposed Sale | 2,627 | $340.90 | $895.5K | — | View → |
| Nov 17, 2025 | Nov 17 9:16 PM | XIAOBIN WU | Proposed Sale | 3,991 | $380.43 | $1.5M | — | View → |
| Nov 13, 2025 | Nov 13 9:22 PM | XIAOBIN WU | Proposed Sale | 6,009 | $380.54 | $2.3M | — | View → |
| Nov 12, 2025 | Nov 12 10:04 PM | XIAOBIN WU | Proposed Sale | 10,000 | $356.02 | $3.6M | — | View → |
| Oct 8, 2025 | Oct 8 8:19 PM | CHAN LEE | Proposed Sale | 13,659 | $341.62 | $4.7M | — | View → |
| Sep 16, 2025 | Sep 16 8:25 PM | PAN-OYLER FOUNDATION | Proposed Sale | 1,204 | $332.27 | $400.1K | — | View → |
| Sep 16, 2025 | Sep 16 8:22 PM | JOHN V OYLER | Proposed Sale | 27,803 | $332.27 | $9.2M | — | View → |
| Sep 10, 2025 | Sep 10 8:37 PM | CHAN LEE | Proposed Sale | 9,010 | $351.13 | $3.2M | — | View → |
| Sep 9, 2025 | Sep 9 8:28 PM | WANG HOLDINGS LLC | Proposed Sale | 5,000 | $346.45 | $1.7M | — | View → |
| Sep 5, 2025 | Sep 5 8:02 PM | CORAZON D. SANDERS | Proposed Sale | 2,665 | $337.00 | $898.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Oct 15 9:08 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 403,364(D) | View → |
| Sep 28, 2026 | Sep 30 9:11 PM | Xiaodong WangDirector, Other | Option Exercise | 403,364 | — | 806,715(D) | View → |
| Sep 8, 2026 | Sep 10 8:49 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 1,210,079(D) | View → |
| Aug 11, 2026 | Aug 14 12:54 AM | Chan Henry LeeSVP, General Counsel | Option Exercise | 34,658 | — | 88,582(D) | View → |
| Jul 22, 2026 | Jul 24 8:51 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 21,697 | — | 98,930(D) | View → |
| Jul 20, 2026 | Jul 22 9:03 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 441,870 | — | 0(D) | View → |
| Jul 17, 2026 | Jul 17 9:36 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 840,164 | — | 441,870(D) | View → |
| Jul 16, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 2,165,761 | — | 1,282,034(D) | View → |
| Jul 15, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,515,241 | — | 1,254,513(D) | View → |
| Jul 14, 2026 | Jul 15 1:26 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,736,800 | — | 462,866(D) | View → |
| Jul 13, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 630,760 | — | 1,264,666(D) | View → |
| Jul 10, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 152,074 | — | 1,895,426(D) | View → |
| Jul 8, 2026 | Jul 10 8:44 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 8,632 | — | 105,300(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Grant/Award | 137,865 | — | 137,865(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Grant/Award | 87,308 | — | 87,308(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Grant/Award | 344,669 | — | 344,669(D) | View → |
| Jun 11, 2026 | Jun 15 9:54 PM | Xiaodong WangDirector, Other | Grant/Award | 193,492 | — | 193,492(D) | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 107,848(D) | View → |
Page 1 of 2
Next →